Daily FNArena News - Australia

Norfolk’s AGM commentary included a reiteration of earnings guidance for FY12 which underscores a Buy rating from Moelis.

A snapshot of economist responses to today’s Australian retail sales and trade balance data.

DJ Carmichael has initiated coverage on Fleetwood with a Hold rating, as strong earnings growth is seen unlikely before FY13.

Despite a weaker market and weaker credit growth expectations, brokers see a lot of value in Australia’s Big Four banks.

Australian houses will remain unaffordable for many years to come, suggests the AMP.

The RBA’s statement had a much damper tone to it this month as it left rates on hold. But don’t get comfortable.

Genetic Technologies is a market leader in the checking of breast cancer risk and the potential upside sees RBS Morgans initiate coverage with a Buy rating.

The RBA today left its cash rate at 4.75%.

Boart Longyear reports interim earnings this month and with global exploration spending increasing both Macquarie and Citi see earnings risk as to the upside.

Westpac says down, ANZ says up. Who’s right?